Cargando…
Evidence for Tissue Toxicity in BALB/c Exposed to a Long-Term Treatment with Oxiranes Compared to Meglumine Antimoniate
Leishmaniasis remains a serious public health problem in developing countries without effective control, whether by vaccination or chemotherapy. Part of the failure of leishmaniasis control is due to the lack of new less toxic and more effective drugs able to eliminate both the lesions and the paras...
Autores principales: | Oliveira, Luiz Filipe Gonçalves, Souza-Silva, Franklin, Cysne-Finkelstein, Léa, Rabelo, Kíssila, Amorim, Juliana Fernandes, Azevedo, Adriana de Souza, Bourguignon, Saulo Cabral, Ferreira, Vitor Francisco, Paes, Marciano Viana, Alves, Carlos Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535747/ https://www.ncbi.nlm.nih.gov/pubmed/28798938 http://dx.doi.org/10.1155/2017/9840210 |
Ejemplares similares
-
The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis
por: Gonçalves-Oliveira, Luiz Filipe, et al.
Publicado: (2019) -
Antileishmanial Activity of 2-Methoxy-4H-spiro-[naphthalene-1,2′-oxiran]-4-one (Epoxymethoxy-lawsone): A Promising New Drug Candidate for Leishmaniasis Treatment
por: Oliveira, Luiz Filipe Gonçalves, et al.
Publicado: (2018) -
Pharmacokinetics of neutron-irradiated meglumine antimoniate in
Leishmania amazonensis-infected BALB/c mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2019) -
Biodistribution of meglumine antimoniate in healthy and
Leishmania (Leishmania) infantum chagasi-infected BALB/c
mice
por: Borborema, Samanta Etel Treiger, et al.
Publicado: (2013) -
FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE
por: Valete-Rosalino, Cláudia Maria, et al.
Publicado: (2014)